
Sign up to save your podcasts
Or


On this episode of Stock Movers:
- Quantum Computing (QUBT) an innovative, integrated photonics and quantum optics technology company, today announced that it has entered into securities purchase agreements with institutional investors for the purchase and sale of 14,035,089 shares of common stock in a private placement at a purchase price of $14.25 per share.
- Fiserv (FI) shares rose as much as 4.5% after the financial-technology company said it plans to launch a stablecoin and platform for its clients. The new platform is slated to be compatible with other stablecoins and enable connection with the other 10,000 financial institutions and millions of merchant locations, according to the company’s press release
- Exelixis (EXEL) shares soars as much as 23% to the highest level since July 2000, after the maker of cancer drugs said topline data for its metastatic colorectal cancer treatment had met one of the dual primary endpoints in the intent-to-treat population.
See omnystudio.com/listener for privacy information.
By iHeartPodcasts4.6
1919 ratings
On this episode of Stock Movers:
- Quantum Computing (QUBT) an innovative, integrated photonics and quantum optics technology company, today announced that it has entered into securities purchase agreements with institutional investors for the purchase and sale of 14,035,089 shares of common stock in a private placement at a purchase price of $14.25 per share.
- Fiserv (FI) shares rose as much as 4.5% after the financial-technology company said it plans to launch a stablecoin and platform for its clients. The new platform is slated to be compatible with other stablecoins and enable connection with the other 10,000 financial institutions and millions of merchant locations, according to the company’s press release
- Exelixis (EXEL) shares soars as much as 23% to the highest level since July 2000, after the maker of cancer drugs said topline data for its metastatic colorectal cancer treatment had met one of the dual primary endpoints in the intent-to-treat population.
See omnystudio.com/listener for privacy information.

406 Listeners

1,173 Listeners

2,175 Listeners

1,993 Listeners

427 Listeners

1,044 Listeners

1,320 Listeners

65 Listeners

64 Listeners

155 Listeners

87 Listeners

80 Listeners

81 Listeners

9 Listeners

11 Listeners